| stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. | during a nosocomial outbreak of infection due to vancomycin-resistant enterococci (vre), rectal swabs that were collected weekly were used to identify and isolate vre carriers. over 6 months, 1,458 stool specimens from 724 high-risk patients were cultured, and 187 vre isolates were recovered from 61 patients; 96% of the isolates were enterococcus faecium. vre tended to be isolated from clinical specimens from patients identified as vre carriers by stool surveillance (p < .01). however, isolation ... | 1995 | 7578758 |
| quinupristin-dalfopristin-resistant enterococcus faecium on chicken and in human stool specimens. | the combination of the streptogramins quinupristin and dalfopristin was approved in the united states in late 1999 for the treatment of vancomycin-resistant enterococcus faecium infections. since 1974, another streptogramin, virginiamycin, has been used at subtherapeutic concentrations to promote the growth of farm animals, including chickens. | 2001 | 11642231 |